Thomas Powles, MD, MRCP, MBBS, is Professor of Genitourinary Oncology and Director of Barts Centre in London, UK. He trained in medical oncology at Imperial College London, completed post-graduate training in oncology in 2005, and received an MD from the University of London in 2006, with a thesis on mechanisms of resistance to therapy in urological cancers.
Professor Powles leads a spectrum of clinical studies from phase 1 to randomized phase 3 investigating novel targeted, biomarkers and immune therapies.
Professor Powles is the lead for solid tumour research at Barts Cancer Institute, leading a spectrum of clinical studies from phase I-III, including biomarker, novel targeted and immune therapies studies.
He has written over 300 peer-reviewed publications including work in all the major journals. Professor Powles participates in and leads a number of guidelines committees.